Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.03p
   
  • Change Today:
      0.025p
  • 52 Week High: 12.50
  • 52 Week Low: 1.98
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 632,383
  • Market Cap: £15.84m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-23 Interim 4.33 (11.79) (2.00)¢ n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 11.88 (5.15) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 4.47 (40.08) (17.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 14.27 (23.81) (5.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 54.00 (10.10) (1.52)p n/a n/a n/a n/a 0.0%
31-Dec-25 108.29 15.92 1.48p 1.4 n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 2.03p
Change Today 0.025p
% Change 1.25 %
52 Week High 12.50
52 Week Low 1.98
Volume 632,383
Shares Issued 782.06m
Market Cap £15.84m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.75% below the market average47.75% below the market average47.75% below the market average47.75% below the market average47.75% below the market average
40.74% above the sector average40.74% above the sector average40.74% above the sector average40.74% above the sector average40.74% above the sector average
Price Trend
95.31% below the market average95.31% below the market average95.31% below the market average95.31% below the market average95.31% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average
Income Not Available
Growth
57.02% above the market average57.02% above the market average57.02% above the market average57.02% above the market average57.02% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:22 4,500 @ 2.05p
15:40 200 @ 2.05p
15:40 487 @ 2.05p
15:36 30,000 @ 2.03p
15:33 4,357 @ 1.99p

Top of Page